Sandoz recently announced a $275 million settlement with its subsidiary Fougera Pharmaceuticals, to resolve allegations of ...

Sandoz Group said it would pay $275 million to settle claims from some plaintiffs in a generics drug pricing antitrust lawsuit in the U.S. The Swiss generics-medicine company said Tuesday that it ...

Both drugs are set to lose protection from a key U.S. patent in February, according to Amgen’s most recent annual report. While Sandoz appears poised to hit the scene with its biosimilars first ...

Your doctor may have prescribed it for another reason. Cyclosporin Sandoz is only available with a doctor's prescription. It is not addictive. Do not take Cyclosporin Sandoz if you have ever had ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

The Felton Police Department have arrested and charged a 43-year-old Camden-Wyoming man on drug related charges after police ...

Teva markets the drug under the name Copaxone, while a generic version of the drug, Glatopa, is sold by Sandoz (SDZ.S), opens new tab. The companies did not immediately respond to requests for ...

The Food and Drug Administration is adding a boxed warning about the risk of an allergic reaction for Teva‘s (TEVA) Copaxone and Sandoz’s ...

Our latest report analyzes the US generic drug landscape, including an industry overview, historical data, deep dives into generic leaders—such as Teva, Sandoz, and Viatris—and more.

In a report released yesterday, Victoria Lambert from Berenberg Bank maintained a Hold rating on Sandoz Group Ltd (SDZXF – Research Report), ...